A Duke University School of Medicine study shows the potential of new imaging technology to change the landscape of breast cancer surgery.

Barbara Sheline, MD, MPH, who has directed the Primary Care Leadership Track (PCLT) program in the Duke University School of Medicine since its establishment in 2011, retired on June 30, 2022.  

Fish oil triglycerides appear to be effective at reducing instances of inflammation in the brain and preventing post-surgical delirium in mice and tissue engineered human models, according to Duke Health and Duke Biomedical Engineering researchers.

A single gene that was previously found to be the driving force in a rare syndrome linked to epilepsy, autism and developmental disability has been identified as a linchpin in the formation of healthy neurons.

The Leadership Development for Researchers (LEADER) Program is designed for junior faculty who are leading a research group and driving their own research agenda.

The Duke Clinical and Translational Science Institute (CTSI) has announced a new opportunity for Duke investigators to obtain biospecimens from the MURDOCK Study for research. The MURDOCK study is a landmark longitudinal cohort of more than 12,000 diverse participants linked to clinical data and up to 14 years of outcomes data.

DukeMed Pride offers LGBTQ students in the School of Medicine a space to find mentors, networking, and a sense of community.

The $27 million grant will fund a new Duke Center for HIV Structural Biology

Mary E. Klotman, MD, has been reappointed for a second five-year term as dean of the Duke University School of Medicine, vice chancellor for health affairs at Duke University, and chief academic officer for Duke University Health System. Her new term begins on July 1, 2022.

The potential end to the Constitutional right to abortion in the U.S. may impact decisions future Ob/Gyns make about their career choices.